Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug - Earth News Report
A sign for the Food and Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.Sarah Silbiger | Getty ImagesA third member of a key Food and Drug Administration advisory panel has resigned over the agency's controversial decision to approve Biogen's new Alzheimer's drug, Aduhelm, CNBC has learned.Dr. Aaron
